Advanced Medical Isotope (OTCMKTS:RDGL) Releases Earnings Results

Advanced Medical Isotope (OTCMKTS:RDGL) issued its earnings results on Monday. The company reported ($0.01) earnings per share for the quarter, Zacks reports. The firm had revenue of $0.02 million during the quarter.

Advanced Medical Isotope Stock Performance

Shares of OTCMKTS:RDGL traded down $0.00 during mid-day trading on Wednesday, hitting $0.09. 435,268 shares of the company traded hands, compared to its average volume of 516,585. The firm’s 50 day simple moving average is $0.08 and its 200 day simple moving average is $0.08. Advanced Medical Isotope has a 52-week low of $0.04 and a 52-week high of $0.17.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.